MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
PerkinElmer DSO Ratio 2011-2025 | PKI
Annual DSO Ratio PerkinElmer
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.6 | 92.9 | 91.3 | 250 | - | 91.8 | 83.1 | 73.4 | 72 | - | 76.8 | 79.2 | 77.9 | 76.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 250 | 72 | 96 |
Quarterly DSO Ratio PerkinElmer
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.6 | 81 | 85.8 | - | 80 | 78.3 | 85.8 | - | 86.5 | 78.1 | 81.1 | - | 94.4 | 95.5 | 100 | 71.6 | 103 | 73.2 | 34.1 | - | 71.3 | 75 | 95.9 | 83.3 | 93.6 | 91.6 | 95.5 | 76.3 | 85.6 | 82.1 | 84 | 78.5 | 90.9 | 92.1 | 85.8 | 68.7 | 78 | 74.2 | 40 | - | 68 | 68 | 76.7 | 70.6 | 79.2 | 77.2 | 80.6 | 72 | 81.6 | 79 | 83.7 | 72.8 | 81.8 | 79.9 | 72.7 | 69.5 | 74.8 | 69.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 34.1 | 79.6 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 16.36 | -4.05 % | $ 176 M |  China |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.63 | -2.11 % | $ 2.07 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 221.54 | -1.96 % | $ 40.2 B | USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 38.85 | 2.32 % | $ 1.08 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Danaher Corporation
DHR
|
57 | $ 227.08 | -2.28 % | $ 166 B | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 11.92 | -6.58 % | $ 338 M |  Israel |
 |
DexCom
DXCM
|
85 | $ 66.91 | -2.94 % | $ 25.8 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 20.44 | 3.23 % | $ 1.1 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.59 | -25.21 % | $ 115 K | USA |
 |
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.58 | 0.21 % | $ 18.8 B | USA |
 |
Co-Diagnostics
CODX
|
101 | $ 0.34 | -2.96 % | $ 9.98 M | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 27.13 | 0.26 % | $ 820 M | USA |
 |
Guardant Health
GH
|
49.2 | $ 102.09 | 0.7 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 134.29 | -1.58 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 192.57 | -0.96 % | $ 9.89 B | USA |
 |
Quidel Corporation
QDEL
|
116 | $ 28.79 | -2.93 % | $ 1.21 B | USA |
 |
Quotient Limited
QTNT
|
45.1 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 182.21 | 0.35 % | $ 20.2 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 7.94 | -1.0 % | $ 1.03 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 263.51 | -0.46 % | $ 22.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 186.28 | -1.92 % | $ 15.4 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
43.6 | $ 701.07 | -0.91 % | $ 57.8 B | USA |
 |
Lantheus Holdings
LNTH
|
72 | $ 66.11 | 4.76 % | $ 4.57 B | USA |
 |
Agilent Technologies
A
|
63.8 | $ 139.44 | -2.4 % | $ 42.4 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.55 | -1.07 % | $ 5.86 M | USA |
 |
Bioventus
BVS
|
92.3 | $ 7.59 | 2.29 % | $ 475 M | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 395.23 | -1.85 % | $ 29.6 B | Schweiz |
 |
Myriad Genetics
MYGN
|
51.3 | $ 7.26 | -0.62 % | $ 658 M | USA |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 5.47 | -7.6 % | $ 2.94 M | USA |